NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win ® technology ...
Hitman: The Board Game has been announced by MOOD Publishing and IO Interactive, with crowdfunding fully funded in 30 minutes ...